European Respiratory Review

Article	Citations
Reply to: “Nicotine or tobacco abstinence?”	324
European Respiratory Review, list of peer reviewers 2022	198
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	160
European Respiratory Review, list of peer reviewers 2023	155
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	137
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	135
Live teleultrasound for evaluation of the chest: a systematic review	135
The role of telemonitoring in patients on home mechanical ventilation	129
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review	111
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	103
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review	101
Exacerbations of bronchiectasis	91
Context-dependent roles of palmitoylation in acute respiratory distress syndrome: integrating inflammation, cell death and repair	87
Recovery of lung function during the first year after COVID-19: a systematic review and meta-analysis	85
Right-sided heart failure in acute respiratory distress syndrome	84
The re-emerging role of linoleic acid in paediatric asthma	83
Advance care planning in patients with respiratory failure	78
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	78
Lung stem cells and respiratory epithelial chimerism in transplantation	77
Air pollution as an early determinant of COPD	76
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	75
Inhaled corticosteroids for the treatment of COVID-19	74
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review	71
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	70
Global respiratory health priorities at the beginning of the 21st century	68

Epidemiology of severe asthma in children: a systematic review and meta-analysis	66
Diaphragm excursion and diaphragm thickening fraction: commonality and conflict	65
Imaging technologies in experimental pulmonary fibrosis research: essential tool for enhanced translational relevance	63
Factors driving outcome variability in aspiration and community-acquired pneumonia: a meta-analysis	60
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis	59
Quantitative lung ultrasound in neonates: tried-and-tested systems simplify bedside use	59
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools	58
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review	57
The ageing of people living with cystic fibrosis: what to expect now?	55
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	54
Sarcopenia in interstitial lung disease	53
Sex and gender in interstitial lung diseases	52
Methods to assess COPD medications adherence in healthcare databases: a systematic review	52
Phenotype overlap in the natural history of asthma	52
Prognostic biomarkers for the development of progressive pulmonary fibrosis in hypersensitivity pneumonitis: a systematic review	51
Nonpharmacological interventions in COPD	49
Pathophysiology and genomics of bronchiectasis	49
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics	47
Smoking cessation and vaccination	47
Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis	46
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review	46
Recreating chronic respiratory infectionsin vitrousing physiologically relevant models	45
Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications	45
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis	44
Sex and gender in respiratory physiology	44
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease	43
REM sleep obstructive sleep apnoea	43
Pro: Clinical remission in asthma – implications for asthma management	41
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an indivi	40
Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis	40
Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review	40
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	40
Sex and gender in pulmonary arterial hypertension	39
Extreme weather and asthma: a systematic review and meta-analysis	39
Airway ciliated cells in adult lung homeostasis and COPD	38
Prevalence and correlates of breathlessness in adults: an umbrella review and updated systematic review with meta-analysis in general and clinical populations	38
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome	38
Bronchiolar disorders in systemic autoimmune rheumatic diseases	38
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	38
Extrapulmonary effects of lung volume reduction in severe emphysema: a systematic review	37
The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects	37
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis	36
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analyses	36
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	36
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours	36
Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics	34
Interplay between respiratory viruses and cilia in the airways	34
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	33
Sex and gender in lung health and disease: more than just Xs and Ys	33
The persistent inflammation in COPD: is autoimmunity the core mechanism?	32

“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	32
Preclinical models of maternal asthma and progeny outcomes: a scoping review	32
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	31
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	31
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	31
Does pulmonary rehabilitation address treatable traits? A systematic review	31
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	31
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	30
The epithelial era of asthma research: knowledge gaps and future direction for patient care	30
New trends in pulmonary hypertension	30
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	30
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	29
Parasitic lung diseases	29
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	29
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	29
Association between air pollution and allergic upper respiratory diseases: a meta-analysis	28
Patient-reported outcome measures for cough used in interstitial lung disease: a systematic review	28
Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review	28
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?	28
The association between alcohol consumption and pulmonary function: a scoping review	28
Effectiveness and safety of home-based versus centre-based exercise programmes for pulmonary hypertension: a systematic review with meta-analysis	28
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens	27
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	27
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	27
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	26
Bronchiectasis in Asia: a review of current status and challenges	25
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	25
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”. Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimb	24
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	24
Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis	24
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	24
Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?	24
From treatable traits to GETomics in airway disease: moving towards clinical practice	24
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	23
Nitrogen single and multiple breath washout test and lung imaging to detect treatment-related pulmonary toxicity in paediatric cancer patients and survivors: a systematic review	23
Managing an ageing cystic fibrosis population: challenges and priorities	23
Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis	23
Digital twins for chronic lung diseases	22
Stem cell therapy in pulmonary hypertension: current practice and future opportunities	22
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis	22
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	21
Biologics in severe asthma: the role of real-world evidence from registries	21
Gait differences between COPD and healthy controls: systematic review and meta-analysis	20
Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review	20
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	20
The 2025 European Cystic Fibrosis Society position statement on physical activity assessment in cystic fibrosis	20
The impact of child and adolescent health on adult respiratory health: the evidence, gaps and priorities	20
Clinical remission in chronic rhinosinusitis with nasal polyps with biologics: a premature promise?	20
Protected characteristics reported in pulmonary rehabilitation: a scoping review	20
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives	19
Antibody-mediated protection against respiratory syncytial virus in children	19
Lung transplantation for COPD/pulmonary emphysema	19
Risk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis	19
Cytokine-targeted therapies for asthma and COPD	19
Determining the minimum important differences for field walking tests in adults with long–term conditions: a systematic review and meta-analysis	19
How inhaled corticosteroids target inflammation in COPD	18
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis	18
Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis	18
The role of evidence-based medicine in the media: misinformation and the COVID-19 lesson	18
Pulmonary rehabilitation and physical interventions	18
The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis	18
Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis	18
In vivodetection of pulmonary mucociliary clearance: present challenges and future directions	18
The effect of graded exercise therapy on fatigue in people with serious respiratory illness: a systematic review	18
Diaphragmatic palsy following lung transplantation	18
Sex and gender in asthma	18
Biomarkers in lower respiratory tract samples in the diagnosis of ventilator-associated pneumonia: a systematic review	17
Clinimetric properties of field exercise tests in cystic fibrosis: a systematic review	17
The 6-min walk test as a primary end-point in interstitial lung disease	17
Ventilation in the obese: physiological insights and management	17
A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome	17
Reporting of pre-existing multiple long-term conditions in physical rehabilitation for long COVID: a scoping review	17
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis	17
“Strength of association between comorbidities and asthma: a meta-analysis” Paola Rogliani, Rossella Laitano, Josuel Ora, Richard Beasley and Luigino Calzetta.Eur Respir Rev2023; 32: 220202	17
The flare of care for rare: per aspera ad astra for rare lung diseases!	16
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	16
End-point definition and trial design to advance tuberculosis vaccine development	16
Forbearance with endobronchial stenting: cognisance before conviction	16
Performance-based outcome measures to assess functionality in hospitalised patients with COPD exacerbations: a systematic review of the measurement properties	16
Biochemical shunt: where and how?	16

Obesity and asthma during pregnancy: a systematic review and meta-analysis	15
Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis	15
Beyond classical collagen: basement membrane collagen IV in age-associated lung diseases	15
CDK4/6 inhibitors in lung cancer: current practice and future directions	15
The evolution ofin vitromodels of lung fibrosis: promising prospects for drug discovery	15
Guidance and standard operating procedures for functional exercise testing in cystic fibrosis	15
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis	14
Towards early detection and disease interception of COPD across the lifespan	14
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	14
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	14
Airway epithelium in lung transplantation: a potential actor for post-transplant complications?	14
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	14
Immune responses of different hosts to Pneumocystis infection	14
“Noninvasive respiratory support after extubation: a systematic review and network meta-analysis”. A. Boscolo, T. Pettenuzzo, N. Sella, M. Zatta, M. Salvagno, M. Tassone, C. Pretto, A. Peralta, L. Mur	14
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	13
Dipeptidyl peptidase-1 inhibitors in bronchiectasis	13
“How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?”. G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.	13
Initiation of antifibrotic treatment in fibrosing interstitial lung disease: is the clock ticking till proven progression?	13
The role of vascularity and the fibrovascular interface in interstitial lung diseases	13
Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms	13
Lung volumes, gas transfer and oscillometry after preterm birth: systematic review and meta-analysis	12
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	12
A beginner's guide to using personalised three-dimensional airway stents	12
EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference	12
Pulmonary veno-occlusive disease: illustrative cases and literature review	12
“Immune mechanisms in fibrotic pulmonary sarcoidosis”. P. Weeratunga, D.R. Moller and L-P. Ho.Eur Respir Rev2022; 31: 220178	12
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis	12
Sex, gender and the pulmonary physiology of exercise	12
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease	12
Managing respiratory muscle weakness during weaning from invasive ventilation	11
Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties	11
Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis	11
Ambient air pollution exposure, mediating biomarkers and risk of COPD: a cohort study and meta-analysis	11
Phage therapy: breathing new tactics into lower respiratory tract infection treatments	11
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review	11
Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis	11
Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection	11
Transient tachypnoea: new concepts on the commonest neonatal respiratory disorder	11
Fine particulate matter manipulates immune response to exacerbate microbial pathogenesis in the respiratory tract	11
Particulate matter-induced epigenetic modifications and lung complications	11
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews	11
Respiratory management of acute chest syndrome in children with sickle cell disease	11
SOX17 in pulmonary arterial hypertension: from development to clinical phenotype	10
Treating central sleep apnoea in heart failure: is positive airway pressure and adaptive servo-ventilation in particular the gold standard?	10
Pulmonary capillary recruitment and distention in mammalian lungs: species similarities	10
Airborne indoor allergen serine proteases and their contribution to sensitisation and activation of innate immunity in allergic airway disease	10
Strength of association between comorbidities and asthma: a meta-analysis	10
Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis	10
Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint	10
Thank you from the Chief Editor (2022–2024)	10
Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target	10
Exploring the translational landscape of the long noncoding RNA transcriptome in acute respiratory distress syndrome: it is a long way to the top	10
Unsupervised home spirometryversussupervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis	10
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians	10
Cellular senescence in adult pulmonary hypertension: current state and future challenges	9
Respiratory muscle dysfunction in acute and chronic respiratory failure: how to diagnose and how to treat?	9
Moderate-to-late prematurity: understanding respiratory consequences and modifiable risk factors	9
European Respiratory Review, list of peer reviewers 2024	9
Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis and trial sequential analysis	9
Neutrophilic inflammation in bronchiectasis	9
Air pollution, metabolites and respiratory health across the life-course	9
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure	9
The impact of smoking on lung cancer patients	9
Pulmonary aspergillosis: diagnosis and treatment	9
Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review	9
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices	9
Animal models of silicosis: fishing for new therapeutic targets and treatments	8
Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review	8
Multidisciplinary management of tracheobronchial injury	8
Post-tuberculosis morbidities and their associated mortality: moving from challenges to solutions	8
Occupation and SARS-CoV-2 in Europe: a review	8
“Sex and gender differences during the lung lifespan: unveiling a pivotal impact” P. Tondo, C. Meschi, M. Mantero, G. Scioscia, M. Siciliano, M. Bradicich and G.M. Stella, on behalf of the Italian Res	8
Con: clinical remission in asthma – not yet there	8
Efficacy and safety of gefapixant for chronic cough: a meta-analysis of randomised controlled trials	8
Rare genetic interstitial lung diseases: a pictorial essay	8
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training	8
Interstitial pneumonia with autoimmune features: challenges and controversies	8
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis	8
Multiple breath washout in primary ciliary dyskinesia: a systematic review of the literature	8
Noncoding RNAs in asthmatic airway smooth muscle cells	8
The deadly dance of alveolar macrophages and influenza virus	8
Home mechanical ventilation in children: evolving indications in an era of new treatment options	8
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?	8
The world of rare interstitial lung diseases	8